Implementation of a comprehensive program including psycho-social and treatment literacy activities to improve adherence to HIV care and treatment for a pediatric population in Kenya
Background To achieve good clinical outcomes with HAART, patient adherence to treatment and care is a key factor. Since the literature on how to care for pediatric HIV patients is limited, we describe here adherence interventions implemented in our comprehensive care program in a resource-limited setting in Kenya. Methods We based our program on factors reported to influence adherence to HIV care and treatment. We describe, in detail, our program with respect to how we adapted our clinical settings, implemented psycho-social support activities for children and their caregivers and developed treatment literacy for children and teenagers living with HIV/AIDS. Results This paper focused on the details of the program, with the treatment outcomes as secondary. However, our program appeared to have been effective; for 648 children under 15 years of age who were started on HAART, the Kaplan-Meier mortality survival estimate was 95.27% (95%CI 93.16–96.74) at 12 months after the time of initiation of HAART. Conclusion Our model of pediatric HIV/AIDS care, focused on a child-centered approach with inclusion of caregivers and extended family, addressed the main factors influencing treatment adherence. It appeared to produce good results and is replicable in resource-limited settings..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2008 |
---|---|
Erschienen: |
2008 |
Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
---|---|
Enthalten in: |
BMC pediatrics - 8(2008), 1 vom: 21. Nov. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Van Winghem, Joelle [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Themen: |
Human Immunodeficiency Virus |
---|
Anmerkungen: |
© Van Winghem et al; licensee BioMed Central Ltd. 2008 |
---|
doi: |
10.1186/1471-2431-8-52 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
SPR027747182 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | SPR027747182 | ||
003 | DE-627 | ||
005 | 20230519085104.0 | ||
007 | cr uuu---uuuuu | ||
008 | 201007s2008 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/1471-2431-8-52 |2 doi | |
035 | |a (DE-627)SPR027747182 | ||
035 | |a (SPR)1471-2431-8-52-e | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Van Winghem, Joelle |e verfasserin |4 aut | |
245 | 1 | 0 | |a Implementation of a comprehensive program including psycho-social and treatment literacy activities to improve adherence to HIV care and treatment for a pediatric population in Kenya |
264 | 1 | |c 2008 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a © Van Winghem et al; licensee BioMed Central Ltd. 2008 | ||
520 | |a Background To achieve good clinical outcomes with HAART, patient adherence to treatment and care is a key factor. Since the literature on how to care for pediatric HIV patients is limited, we describe here adherence interventions implemented in our comprehensive care program in a resource-limited setting in Kenya. Methods We based our program on factors reported to influence adherence to HIV care and treatment. We describe, in detail, our program with respect to how we adapted our clinical settings, implemented psycho-social support activities for children and their caregivers and developed treatment literacy for children and teenagers living with HIV/AIDS. Results This paper focused on the details of the program, with the treatment outcomes as secondary. However, our program appeared to have been effective; for 648 children under 15 years of age who were started on HAART, the Kaplan-Meier mortality survival estimate was 95.27% (95%CI 93.16–96.74) at 12 months after the time of initiation of HAART. Conclusion Our model of pediatric HIV/AIDS care, focused on a child-centered approach with inclusion of caregivers and extended family, addressed the main factors influencing treatment adherence. It appeared to produce good results and is replicable in resource-limited settings. | ||
650 | 4 | |a Human Immunodeficiency Virus |7 (dpeaa)DE-He213 | |
650 | 4 | |a Human Immunodeficiency Virus Testing |7 (dpeaa)DE-He213 | |
650 | 4 | |a Treatment Literacy |7 (dpeaa)DE-He213 | |
650 | 4 | |a Human Immunodeficiency Virus Status |7 (dpeaa)DE-He213 | |
650 | 4 | |a Human Immunodeficiency Virus Care |7 (dpeaa)DE-He213 | |
700 | 1 | |a Telfer, Barbara |4 aut | |
700 | 1 | |a Reid, Tony |4 aut | |
700 | 1 | |a Ouko, Judith |4 aut | |
700 | 1 | |a Mutunga, Angela |4 aut | |
700 | 1 | |a Jama, Zaina |4 aut | |
700 | 1 | |a Vakil, Shobha |4 aut | |
773 | 0 | 8 | |i Enthalten in |t BMC pediatrics |d London : BioMed Central, 2001 |g 8(2008), 1 vom: 21. Nov. |w (DE-627)SPR027744639 |w (DE-600)2041342-7 |x 1471-2431 |7 nnns |
773 | 1 | 8 | |g volume:8 |g year:2008 |g number:1 |g day:21 |g month:11 |
856 | 4 | 0 | |u https://dx.doi.org/10.1186/1471-2431-8-52 |z kostenfrei |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_SPRINGER | ||
912 | |a SSG-OLC-PHA | ||
951 | |a AR | ||
952 | |d 8 |j 2008 |e 1 |b 21 |c 11 |